Synthesis 2014; 46(13): 1751-1756
DOI: 10.1055/s-0033-1341104
paper
© Georg Thieme Verlag Stuttgart · New York

A New Enantioselective Synthesis of the Anti-Parkinson Agent Safinamide

Anjaneyulu Reddi
Division of Organic Chemistry, CSIR-National Chemical Laboratory, Dr. Homibhabha Road, Pune 411 008, India   Fax: +91(20)25902629   Email: m.muthukrishnan@ncl.res.in
,
Mohammad Mujahid
Division of Organic Chemistry, CSIR-National Chemical Laboratory, Dr. Homibhabha Road, Pune 411 008, India   Fax: +91(20)25902629   Email: m.muthukrishnan@ncl.res.in
,
Murugesan Sasikumar
Division of Organic Chemistry, CSIR-National Chemical Laboratory, Dr. Homibhabha Road, Pune 411 008, India   Fax: +91(20)25902629   Email: m.muthukrishnan@ncl.res.in
,
Murugan Muthukrishnan*
Division of Organic Chemistry, CSIR-National Chemical Laboratory, Dr. Homibhabha Road, Pune 411 008, India   Fax: +91(20)25902629   Email: m.muthukrishnan@ncl.res.in
› Author Affiliations
Further Information

Publication History

Received: 13 January 2014

Accepted after revision: 13 March 2014

Publication Date:
02 April 2014 (online)


Abstract

An alternative highly enantioselective synthesis of the anti-Parkinson agent safinamide from simple, commercially available, starting materials is described. The protocol might also be useful in the synthesis of structural variants of safinamide, such as ralfinamide or related analogues

Supporting Information